EFG Asset Management (Americas)’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $245K | Sell |
|
|||||
|
2023
Q4 | $370K | Sell |
|
|||||
|
2023
Q3 | $362K | Buy |
|
|||||
|
2023
Q2 | $296K | Buy |
|
|||||
|
2023
Q1 | $270K | Buy |
|
|||||
|
2022
Q4 | $247K | Sell |
|
|||||
|
2022
Q3 | $233K | Hold |
|
|||||
|
2022
Q2 | $214K | Sell |
|
|||||
|
2022
Q1 | $218K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $1.75M | Buy |
|
|||||
|
2019
Q4 | $2.15M | Sell |
|
|||||
|
2019
Q3 | $2.2M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $1.58M | Buy |
|
|||||
|
2018
Q3 | $2.44M | Buy |
|